GSBR-5595
/ Structure Therap
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
June 20, 2025
Structure Therapeutics Announces…Late-Breaking Poster Presentations at the American Diabetes Association 85th Scientific Sessions…
(GlobeNewswire)
- "Structure Therapeutics...announced...upcoming late-breaking poster presentations at the American Diabetes Association 85th Scientific Sessions....In a Parkinson’s disease mouse model, oral administration of GSBR-5595...significantly improved motor coordination and movement in both the rotarod and open field tests. Additionally, histopathological analyses revealed a significant increase in dopaminergic neurons."
Late-breaking abstract • Preclinical • Parkinson's Disease
1 to 1
Of
1
Go to page
1